Wei Lin
CIK 0001872772
Chief Medical OfficerDirector
Filings
12
Latest Mar 19, 2026
Issuers covered
3
Showing
12 of 12
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 25% | -20.8% | -18.1% | +3.4% | -50.6% |
| 90 days | 3 | 0% | -37.7% | -20.1% | -16.2% | -76.7% |
| 180 days | 3 | 0% | -80.2% | -98.6% | -20.5% | -121.5% |
| 365 days | 1 | 0% | -5.5% | -5.5% | -5.5% | -5.5% |
Issuers
Companies where Wei Lin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | 6 | Mar 19, 2026 |
| TSVT | 2seventy Bio, Inc. | 4 | May 15, 2025 |
| ERAS | Erasca, Inc. | 2 | Feb 3, 2023 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|